Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online September 5, 2011

Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis

Abstract

The objective of the present study was to elucidate the association between glomerular complement depositions belonging to the alternative (AP) and lectin (LP) pathways, and clinical findings of lupus nephritis (LN). Immunofluorescence (IF) was performed on 17 LN patients using antibodies against factor B, factor H, properdin, mannose-binding lectin (MBL) and L-ficolin. Compared with factor B/factor H negative patients (n = 9), positive patients (n = 8) showed longer duration of LN (p < 0.05) and more severe interstitial fibrosis (p < 0.05). Eleven patients had properdin deposition in glomeruli, and in three of them, with a duration of LN of less than 1 month, factor B was undetectable. Compared with properdin negative patients (n = 6), positive patients (n = 11) showed significantly higher urinary protein excretion (p < 0.01). MBL/L-ficolin positive patients (n = 11) also had significantly higher urinary protein excretion (p < 0.05) compared with negative patients (n = 6). An independent association was found between glomerular deposition of properdin and that of MBL/L-ficolin (p < 0.01) in addition to factor B/factor H. Traces of glomerular activation of AP and LP reflected the clinical status of LN. It appears that glomerular deposition of each complement component, especially properdin, may be an index of the histological activity of LN.

Get full access to this article

View all access and purchase options for this article.

References

1. Rothfield N, Ross HA, Minta JO, Lepow IH. Glomerular and dermal deposition of properdin in systemic lupus erythematosus. N Engl J Med 1972; 287: 681–685.
2. Wyatt RJ, McAdams AJ, Forristal J, Snyder J, West CD. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis. Kidney Int 1979; 16: 505–512.
3. Lhotta K, Wuzner R, Konig P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant 1999; 14: 881–886.
4. Matsushita M, Endo Y, Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 2000; 164: 2281–2284.
5. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002; 168: 3502–3506.
6. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38: 133–149.
7. Holmskov U, Thiel S, Jensenius JC. Collectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547–578.
8. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 76: 1497–1502.
9. Matsushita M, Fujita T. Cleavage of the third component of complement (C3) by mannose-binding protein associated serine protease (MASP) with subsequent complement activation. Immunobiol 1995; 194: 443–448.
10. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 1994; 6: 665–669.
11. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 1998; 13: 1984–1990.
12. Lachmann PJ. The amplification loop of the complement pathways. Adv Immunol 2009; 104: 115–149.
13. Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 2006; 281: 2128–2132.
14. Kemper C, Mitchell LM, Zhang L, Hourcade DE. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci U S A 2008; 105: 9023–9028.
15. Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 2007; 179: 2600–2608.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.
17. Matsushita M, Endo Y, Taira S, et al. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996; 271: 2448–2454.
18. Harboe M, Mollnes TE. The alternative complement pathway revisited. J Cell Mol Med 2008; 12: 1074–1084.
19. Xu W, Berger SP, Trouw LA, et al. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol 2008; 180: 7613–7621.
20. Sato N, Ohsawa I, Takagi M, et al. Type B insulin resistance syndrome with systemic lupus erythematosus. Clin Nephrol 2010; 73: 157–162.
21. Xing GQ, Chen M, Liu G, Zheng XJE, Zhao MH. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30: 144–156.
22. Seelen MA, Roos A, Daha MR. Role of complement in innate and autoimmunity. J Nephrol 2005; 18: 642–653.
23. Watanabe H, Garnier G, Circolo A, et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 2000; 164: 786–794.
24. Nolan KF, Reid KB. Properdin. Methods Enzymol 1993; 223: 35–46.
25. Kohler PF, Muller-Eberhard HJ. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. J Immunol 1967; 99: 1211–1216.
26. Oglesby TJ, Ueda A, Volanakis JE. Radioassays for quantitation of intact complement proteins C2 and B in human serum. J Immunol Methods 1988; 110: 55–62.
27. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996; 27: 765–775.
28. Tang S, Leung JC, Tsang AW, Lan HY, Chan TM, Lai KN. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int 2002; 61: 1655–1665.
29. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9–17.
30. Nangaku M, Pippin J, Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 1999; 10: 2323–2331.
31. Siezenga MA, van der Geest RN, Mallat MJ, Rabelink TJ, Daha MR, Berger SP. Urinary properdin excretion is associated with internal complement activation and poor renal function. Nephrol Dial Transplant 2010; 25: 1157–1161.
32. Fadok VA, Henson PM. Apoptosis: giving phosphatidylserine recognition an assist–with a twist. Curr Biol 2003; 3: 655–657.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Pages: 1378 - 1386
Article first published online: September 5, 2011
Issue published: November 2011

Keywords

  1. alternative pathway
  2. complement
  3. lectin pathway
  4. lupus nephritis
  5. properdin

Rights and permissions

© The Author(s), 2011. Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav.
Request permissions for this article.
PubMed: 21893562

Authors

Affiliations

N Sato
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
I Ohsawa
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
S Nagamachi
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
M Ishii
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
G Kusaba
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
H Inoshita
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
A Toki
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
S Horikoshi
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
H Ohi
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan
M Matsushita
Department of Applied Biochemistry, Tokai University, Japan
Y Tomino
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Japan

Notes

Correspondence to : Yasuhiko Tomino, Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Lupus.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 276

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 59 view articles Opens in new tab

Crossref: 58

  1. Clinicopathological characteristics and outcomes of lupus nephritis pa...
    Go to citation Crossref Google Scholar
  2. Complement therapeutics are coming of age in rheumatology
    Go to citation Crossref Google Scholar
  3. The role of complement in glomerulonephritis—are novel therapies ready...
    Go to citation Crossref Google Scholar
  4. Differentiating between activation via the lectin or the classical com...
    Go to citation Crossref Google Scholar
  5. Kidney diseases
    Go to citation Crossref Google Scholar
  6. Contributions of animal models to mechanistic understandings of antibo...
    Go to citation Crossref Google Scholar
  7. Thrombotic microangiopathy mediates poor prognosis among lupus nephrit...
    Go to citation Crossref Google Scholar
  8. Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocyt...
    Go to citation Crossref Google Scholar
  9. Relationship of complement activation pathway to clinical and patholog...
    Go to citation Crossref Google Scholar
  10. Role of complement components in vasculitic neuropathy associated with...
    Go to citation Crossref Google Scholar
  11. Intertwined pathways of complement activation command the pathogenesis...
    Go to citation Crossref Google Scholar
  12. Comparison of Complement Pathway Activation in Autoimmune Glomerulonep...
    Go to citation Crossref Google Scholar
  13. C4d as a Screening Tool and an Independent Predictor of Clinical Outco...
    Go to citation Crossref Google Scholar
  14. Proteolysis and inflammation of the kidney glomerulus
    Go to citation Crossref Google Scholar
  15. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Pa...
    Go to citation Crossref Google Scholar
  16. Alternative complement pathway activation in thrombotic microangiopath...
    Go to citation Crossref Google Scholar
  17. Expanding the Role of Complement Therapies: The Case for Lupus Nephrit...
    Go to citation Crossref Google Scholar
  18. Activation of the alternative complement pathway predicts renal outcom...
    Go to citation Crossref Google ScholarPub Med
  19. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lu...
    Go to citation Crossref Google Scholar
  20. Role of properdin in complement-mediated kidney diseases
    Go to citation Crossref Google Scholar
  21. Glomerular membrane attack complex is not a reliable marker of ongoing...
    Go to citation Crossref Google Scholar
  22. The lectin pathway in renal disease: old concept and new insights
    Go to citation Crossref Google Scholar
  23. Thrombotic Microangiopathies with Rheumatologic Involvement
    Go to citation Crossref Google Scholar
  24. Antibodies targeting circulating protective molecules in lupus nephrit...
    Go to citation Crossref Google Scholar
  25. Erythrocyte and glomerular C4d deposits as a biomarker for active lupu...
    Go to citation Crossref Google Scholar
  26. Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in...
    Go to citation Crossref Google Scholar
  27. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-...
    Go to citation Crossref Google Scholar
  28. Serum complement factor I is associated with disease activity of syste...
    Go to citation Crossref Google Scholar
  29. Basement Membrane Defects in Genetic Kidney Diseases
    Go to citation Crossref Google Scholar
  30. Genetic variants in FH are associated with renal histopathologic subty...
    Go to citation Crossref Google ScholarPub Med
  31. At the Cross Section of Thrombotic Microangiopathy and Atypical Hemoly...
    Go to citation Crossref Google Scholar
  32. The alternative complement pathway is dysregulated in patients with ch...
    Go to citation Crossref Google Scholar
  33. Differential activation mechanisms of serum C5a in lupus nephritis and...
    Go to citation Crossref Google Scholar
  34. Complement Alternative Pathway׳s Activation in Patients With Lupus Nep...
    Go to citation Crossref Google Scholar
  35. Glomerular basement membrane heparan sulfate in health and disease: A ...
    Go to citation Crossref Google Scholar
  36. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Bio...
    Go to citation Crossref Google Scholar
  37. The Level of IgA Antibodies to Endothelial Cells Correlates with Histo...
    Go to citation Crossref Google Scholar
  38. The dysfunctions of complement factor H in lupus nephritis
    Go to citation Crossref Google ScholarPub Med
  39. Association between the Presence of Autoantibodies Targeting Ficolin-3...
    Go to citation Crossref Google Scholar
  40. BF*F allotype of the alternative pathway of complement: A marker of pr...
    Go to citation Crossref Google ScholarPub Med
  41. Complement Activation
    Go to citation Crossref Google Scholar
  42. Systemic Lupus Erythematosus
    Go to citation Crossref Google Scholar
  43. Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumat...
    Go to citation Crossref Google Scholar
  44. Case report: lupus nephritis with autoantibodies to complement alterna...
    Go to citation Crossref Google Scholar
  45. Anti-C1q autoantibodies from systemic lupus erythematosus patients act...
    Go to citation Crossref Google Scholar
  46. Clinical Significance of Renal Interstitial Fibrosis in Patients with ...
    Go to citation Crossref Google Scholar
  47. Properdin has an ascendancy over factor H regulation in complement-med...
    Go to citation Crossref Google Scholar
  48. Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangi...
    Go to citation Crossref Google Scholar
  49. Mannose binding lectin deposition in skin of lupus erythematosus patie...
    Go to citation Crossref Google Scholar
  50. Clinicopathological Characteristics and Outcomes of Chinese Patients w...
    Go to citation Crossref Google Scholar
  51. Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in A...
    Go to citation Crossref Google Scholar
  52. Deposition of the lectin pathway of complement in renal biopsies of lu...
    Go to citation Crossref Google Scholar
  53. Circulating complement activation in patients with anti-neutrophil cyt...
    Go to citation Crossref Google Scholar
  54. The spectrum of renal thrombotic microangiopathy in lupus nephritis
    Go to citation Crossref Google Scholar
  55. Nephritogenic-antinephritogenic antibody network in lupus glomerulonep...
    Go to citation Crossref Google ScholarPub Med
  56. Lupus nephritis: A critical review
    Go to citation Crossref Google Scholar
  57. Determination of Severity of Murine IgA Nephropathy by Glomerular Comp...
    Go to citation Crossref Google Scholar
  58. Pathological Scenario with the Mannose-Binding Lectin in Patients with...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text